وبلاگ اختصاصی دکتر علیرضا طالبیان

جراح دندانپزشک نظام پزشکی 67843

وبلاگ اختصاصی دکتر علیرضا طالبیان - مراجع-و-رفرنس-های-دوره-کنترل-عفونت

دکتر طالبیان
وبلاگ اختصاصی دکتر علیرضا طالبیان جراح دندانپزشک نظام پزشکی 67843

2 مراجع و رفرنس های دوره کنترل عفونت
  1. Turjanmaa K, Reunala T, Alenius H, Brummer-Korvenkontio H,
    Palosuo T. Allergens in latex surgical gloves and glove powder. Lancet
    1990;336:1588.
  2. Baur X, Chen Z, Allmers H. Can a threshold limit value for natural
    rubber latex airborne allergens be defined? J Allergy Clin Immunol
    1998;101:24–7.
  3. Trape M, Schenck P, Warren A. Latex gloves use and symptoms in
    health care workers 1 year after implementaion of a policy restricting
    the use of powdered gloves. Am J Infec Control 2000;28:352–8.
  4. Allmers H, Brehler R, Chen Z, Raulf-Heimsoth M, Fels H, Baur X.
    Reduction of latex aeroallergens and latex-specific IgE antibodies in
    sensitized workers after removal of powdered natural rubber latex gloves
    in a hospital. Allergy Clin Immunol 1998;102:841–6.
  5. Tarlo SM, Sussman G, Contala A, Swanson MC. Control of airborne
    latex by use of powder-free latex gloves. J Allergy Clin Immunol
    1994;93:985–9.
  6. Swanson MC, Bubak ME, Hunt LW, Yunginger JW, Warner MA, Reed
    CE. Quantification of occupational latex aeroallergens in a medical
    center. J Allergy Clin Immunol 1994;94:445–551.
  7. Hermesch CB, Spackman GK, Dodge WW, Salazar A. Effect of
    powder-free latex examination glove use on airborne powder levels in a
    dental school clinic. J Dent Educ 1999;63:814–20.
  8. Miller CH. Infection control strategies for the dental office [Chapter
    29]. In: Ciancio SG, ed. ADA guide to dental therapeutics. 2nd ed.
    Chicago, IL: ADA Publishing, 2000:543–58.
  9. Primeau MN, Adkinson NF Jr, Hamilton RG. Natural rubber pharmaceutical vial closures release latex allergens that produce skin reactions. J Allergy Clin Immunol 2001;107:958–62.
  10. Spaulding EH. Chemical disinfection of medical and surgical materials [Chapter 32]. In: Lawrence CA, Block SS, eds. Disinfection, sterilization and preservation. Philadelphia, PA: Lea & Febiger, 1968:
    517–31.
  11. CDC. Guideline for disinfection and sterilization in healthcare facilities: recommendations of CDC and the Healthcare Infection Control
    Practices Advisory Committee (HICPAC). MMWR (in press).
  12. CDC. Guidelines for environmental infection control in health-care
    facilities: recommendations of CDC and the Healthcare Infection
    Control Practices Advisory Committee (HICPAC). MMWR
    2003;52(No. RR-10).
    Vol. 52 / RR-17 Recommendations and Reports 55
  13. US Environmental Protection Agency. 40 CFR Parts 152, 156, and
  14. Exemption of certain pesticide substances from federal insecticide, fungicide, and rodenticide act requirements. Amended 1996.
    Federal Register 1996;61:8876–9.
  15. Food and Drug Administration. Dental handpiece sterilization [Letter]. Rockville, MD: US Department of Health and Human Services,
    Food and Drug Administration, 1992.
  16. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Steam sterilization and sterility
    assurance in health care facilities. ANSI/AAMI ST46-2002. Arlington, VA: Association for the Advancement of Medical Instrumentation, 2002.
  17. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Steam sterilization and sterility
    assurance using table-top sterilizers in office-based, ambulatory-care
    medical, surgical, and dental facilities. ANSI/AAMI ST40-1998.
    Arlington, VA: Association for the Advancement of Medical Instrumentation, 1998.
  18. Favero MS, Bond WW. Chemical disinfection of medical and surgical
    material [Chapter 43]. In: Block SS, ed. Disinfection, sterilization and
    preservation. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins,
    2001:881–917.
  19. Parker HH 4th, Johnson RB. Effectiveness of ethylene oxide for sterilization of dental handpieces. J Dent 1995;23:113–5.
  20. Alfa MJ, Olson N, Degagne P, Hizon R. New low temperature sterilization technologies: microbicidal activity and clinical efficacy [Chapter 9]. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in
    health-care. Champlain, NY: Polyscience Publications, 1998:67–78.
  21. Rutala WA, Weber DJ. Clinical effectiveness of low-temperature
    sterilization technologies. Infect Control Hosp Epidemiol 1998;
    19:798–804.
  22. Miller CH, Tan CM, Beiswanger MA, Gaines DJ, Setcos JC, Palenik
    CJ. Cleaning dental instruments: measuring the effectiveness of an
    instrument washer/disinfector. Am J Dent 2000;13:39–43.
  23. Association for the Advancement of Medical Instrumentation. Chemical indicators—guidance for the selection, use, and interpretation of
    results. AAMI Technical Information Report No. 25. Arlington, VA:
    Association for the Advancement of Medical Instrumentation, 1999.
  24. Ninemeier J. Central service technical manual. 5th ed. Chicago, IL:
    International Association of Healthcare Central Service Materiel Management, 1998.
  25. Rutala WA, Weber DJ. Choosing a sterilization wrap for surgical packs.
    Infection Control Today 2000;4:64,70.
  26. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Good hospital practice: steam sterilization and sterility assurance. ANSI/AAMI ST46-1993. Arlington, VA:
    Association for the Advancement of Medical Instrumentation, 1993.
  27. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Flash sterilization: steam sterilization of patient care items for immediate use. ANSI/AAMI ST37-1996.
    Arlington, VA: Association for the Advancement of Medical Instrumentation, 1996.
  28. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Ethylene oxide sterilization in health
    care facilities: safety and effectiveness. ANSI/AAMI ST41-1999.
    Arlington, VA: Association for the Advancement of Medical Instrumentation, 1999.
  29. Miller CH, Palenik CJ. Sterilization, disinfection, and asepsis in dentistry [Chapter 53]. In: Block SS, ed. 5th ed. Disinfection, sterilization, and preservation. Philadelphia, PA: Lippincott Williams &
    Wilkins, 2001:1049–68.
  30. Joslyn LJ. Sterilization by heat [Chapter 36]. In: Block SS, ed. 5th ed.
    Disinfection, sterilization, and preservation. Philadelphia, PA:
    Lippincott Williams & Wilkins, 2001:695–728.
  31. Rutala WA, Weber DJ, Chappell KJ. Patient injury from flashsterilized instruments. Infect Control Hosp Epidemiol 1999;20:458.
  32. Bond WW. Biological indicators for a liquid chemical sterilizer: a solution to the instrument reprocessing problem? Infect Control Hosp
    Epidemiol 1993;14:309–12.
  33. Stingeni L, Lapomarda V, Lisi P. Occupational hand dermatitis in hospital environments. Contact Dermatitis 1995;33:172–6.
  34. Ashdown BC, Stricof DD, May ML, Sherman SJ, Carmody RF.
    Hydrogen peroxide poisoning causing brain infarction: neuroimaging
    findings. Am J Roentgenol 1998;170:1653–5.
  35. Ballantyne B. Toxicology of glutaraldehyde: review of studies and
    human health effects. Danbury, CT: Union Carbide, 1995.
  36. CDC. National Institute for Occupational Safety and Health. Glutaraldehyde: occupational hazards in hospitals. Cincinnati, OH: US
    Department of Health and Human Services, Public Health Service,
    CDC, National Institute for Occupational Safety and Health, 2001.
    DHHS publication no. (NIOSH) 2001-115.
    268 CDC. Epidemiologic notes and reports: symptoms of irritation associated with exposure to glutaraldehyde—Colorado. MMWR
    1987;36:190–1.
  37. Lehman PA, Franz TJ, Guin JD. Penetration of glutaraldehyde through
    glove material: tactylon versus natural rubber latex. Contact Dermatitis 1994;30:176–7.
  38. Hamann CP, Rodgers PA, Sullivan K. Allergic contact dermatitis in
    dental professionals: effective diagnosis and treatment. J Am Dent Assoc
    2003;134:185–94.
  39. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Safe use and handling of glutaraldehyde-based products in health care facilities. ANSI/AAMI ST58-1996.
    Arlington, VA: Association for the Advancement of Medical Instrumentation, 1996.
  40. Fisher AA. Ethylene oxide dermatitis. Cutis 1984;34:20, 22, 24.
  41. Jay WM, Swift TR, Hull DS. Possible relationship of ethylene oxide
    exposure to cataract formation. Am J Ophthalmol 1982;93:727–32.
  42. US Department of Labor, Occupational Safety and Health Administration. Review of the ethylene oxide standard. Federal Register
    2000;65:35127–8.
  43. Pratt LH, Smith DG, Thornton RH, Simmons JB, Depta BB, Johnson
    RB. The effectiveness of two sterilization methods when different
    precleaning techniques are employed. J Dent 1999;27:247–8.
  44. US Department of Health and Human Services, Food and Drug
    Administration. 21 CFR Part 872.6730. Dental devices; endodontic
    dry heat sterilizer; final rule. Federal Register 1997;62:2903.
  45. Favero MS. Current issues in hospital hygiene and sterilization technology. J Infect Control (Asia Pacific Edition) 1998;1:8–10.
  46. Greene WW. Control of sterilization process [Chapter 22]. In: Russell
    AD, Hugo WB, Ayliffe GA, eds. Principles and practice of disinfection, preservation, and sterilization. Oxford, England: Blackwell Scientific Publications, 1992:605–24.
    56 MMWR December 19, 2003
  47. Favero MS. Developing indicators for sterilization [Chapter 13]. In:
    Rutala W, ed. Disinfection, sterilization, and antisepsis in health care.
    Washington, DC: Association for Professionals in Infection Control
    and Epidemiology, Inc., 1998:119–32.
  48. Maki DG, Hassemer CA. Flash sterilization: carefully measured haste.
    Infect Control 1987;8:307–10.
  49. Andres MT, Tejerina JM, Fierro JF. Reliability of biologic indicators in
    a mail-return sterilization-monitoring service: a review of 3 years.
    Quintessence Int 1995;26:865–70.
  50. Miller CH, Sheldrake MA. The ability of biological indicators to
    detect sterilization failures. Am J Dent 1994;7:95–7.
  51. Association of Operating Room Nurses. AORN standards and recommended practices for perioperative nursing. Denver, CO: AORN, 1987.
  52. Mayworm D. Sterile shelf life and expiration dating. J Hosp Supply
    Process Distrib 1984;2:32–5.
  53. Cardo DM, Sehulster LM. Central sterile supply [Chapter 65]. In:
    Mayhall CG, ed. Hospital Epidemiology and Infection Control. 2nd
    ed. Philadelphia, PA: Lippincott Williams & Wilkins, 1999:1023–30.
  54. Maki DG, Alvarado CJ, Hassemer CA, Zilz MA. Relation of the
    inanimate hospital environment to endemic nosocomial infection.
    N Engl J Med 1982;307:1562–6.
  55. Danforth D, Nicolle LE, Hume K, Alfieri N, Sims H. Nosocomial
    infections on nursing units with floors cleaned with a disinfectant compared with detergent. J Hosp Infect 1987;10:229–35.
  56. Crawford JJ. Clinical asepsis in dentistry. Mesquite, TX: Oral Medicine Press, 1987.
  57. Food and Drug Administration. Design control guidance for medical
    device manufacturers. Rockville, MD: US Department of Health and
    Human Services, Food and Drug Administration, 1997.
  58. Fauerbach LL, Janelle JW. Practical applications in infection control
    [Chapter 45]. In: Block SS, ed. 5th ed. Disinfection, sterilization, and
    preservation. Philadelphia, PA: Lippincott Williams & Wilkins,
    2001:935–44.
  59. Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation
    of the human T lymphotrophic virus type III/lymphadenopathyassociated virus. J Infect Dis 1985;152:400–3.
  60. Bloomfield SF, Smith-Burchnell CA, Dalgleish AG. Evaluation of
    hypochlorite-releasing disinfectants against the human immunodeficiency virus (HIV). J Hosp Infect 1990;15:273–8.
  61. Gerson SL, Parker P, Jacobs MR, Creger R, Lazarus HM. Aspergillosis
    due to carpet contamination. Infect Control Hosp Epidemiol
    1994;15:221–3.
  62. Suzuki A, Namba Y, Matsuura M, Horisawa A. Bacterial contamination of floors and other surfaces in operating rooms: a five–year survey.
    J Hyg (Lond) 1984;93:559–66.
  63. Skoutelis AT, Westenfelder GO, Beckerdite M, Phair JP. Hospital carpeting and epidemiology of Clostridium difficile. Am J Infect Control
    1994;22:212–7.
  64. Rutala WA, Odette RL, Samsa GP. Management of infectious waste
    by US hospitals. JAMA 1989;262:1635–40.
  65. CDC. Perspectives in disease prevention and health promotion. Summary of the Agency for Toxic Substances and Disease Registry report
    to Congress: the public health implications of medical waste. MMWR
    1990; 39:822–4.
  66. Palenik CJ. Managing regulated waste in dental environments.
    J Contemp Dent Pract 2003;4:76.
  67. Rutala WA, Mayhall CG. Medical waste. Infect Control Hosp
    Edidemiol 1992;13:38–48.
  68. Greene R, State and Territorial Association on Alternate Treatment
    Technologies. Technical assistance manual: state regulatory oversight
    of medical waste treatment technologies. 2nd ed. Washington, DC:
    US Environmental Protection Agency, 1994. Available at http://www.
    epa.gov/epaoswer/other/medical/mwpdfs/ta/1.pdf.
  69. US Environmental Protection Agency. 40 CFR Part 60. Standards of
    performance for new stationary sources and emission guidelines for
    existing sources: hospital/medical/infectious waste incinerators; final
    rule. Federal Register 1997;62:48347–91.
  70. Slade JS, Pike EB, Eglin RP, Colbourne JS, Kurtz JB. The survival of
    human immunodeficiency virus in water, sewage, and sea water. Water
    Sci Tech 1989;21:55–9.
  71. Walker JT, Bradshaw DJ, Bennett AM, Fulford MR, Martin MV, Marsh
    PD. Microbial biofilm formation and contamination of dental-unit
    water systems in general dental practice. Appl Environ Microbiol
    2000;66:3363–7.
  72. Schulze-Robbecke R, Feldmann C, Fischeder R, Janning B, Exner M,
    Wahl G. Dental units: an environmental study of sources of potentially pathogenic mycobacteria. Tuber Lung Dis 1995;76:318–23.
  73. Barbeau J, Tanguay R, Faucher E, et al. Multiparametric analysis of
    waterline contamination in dental units. Appl Environ Microbiol
    1996;62:3954–9.
  74. Atlas RM, Williams JF, Huntington MK. Legionella contamination of
    dental-unit waters. Appl Environ Microbiol 1995;61:1208–13.
  75. Kelstrup J, Funder-Nielsen T, Theilade J. Microbial aggregate contamination of water lines in dental equipment and its control. Acta Pathol
    Microbiol Scand [B] 1977;85:177–83.
  76. Challacombe SJ, Fernandes LL. Detecting Legionella pneumophila in
    water systems: a comparison of various dental units. J Am Dent Assoc
    1995;126:603–8.
  77. Mayo JA, Oertling KM, Andrieu SC. Bacterial biofilm: a source of contamination in dental air-water syringes. Clin Prev Dent 1990;12:13–20.
  78. Scheid RC, Kim CK, Bright JS, Whitely MS, Rosen S. Reduction of
    microbes in handpieces by flushing before use. J Am Dent Assoc
    1982;105:658–60.
  79. Bagga BS, Murphy RA, Anderson AW, Punwani I. Contamination of
    dental unit cooling water with oral microorganisms and its prevention. J Am Dent Assoc 1984;109:712–6.
  80. Martin MV. The significance of the bacterial contamination of dental
    unit water systems. Br Dent J 1987;163:152–4.
  81. Pankhurst CL, Philpott-Howard JN, Hewitt JH, Casewell MW. The
    efficacy of chlorination and filtration in the control and eradication of
    Legionella from dental chair water systems. J Hosp Infect 1990;16:9–18.
  82. Mills SE, Lauderdale PW, Mayhew RB. Reduction of microbial contamination in dental units with povidone-iodine 10%. J Am Dent
    Assoc 1986;113:280–4.
  83. Williams JF, Johnston AM, Johnson B, Huntington MK, Mackenzie
    CD. Microbial contamination of dental unit waterlines: prevalence,
    intensity and microbiological characteristics. J Am Dent Assoc
    1993;124:59–65.
  84. Mills SE. The dental unit waterline controversy: defusing the myths,
    defining the solutions. J Am Dent Assoc 2000;131:1427–41.
  85. Jones F, Bartlett CL. Infections associated with whirlpools and spas.
    Soc Appl Bacteriol Symp Ser 1985;14:61S–6S.
  86. Hollyoak V, Allison D, Summers J. Pseudomonas aeruginosa wound
    infection associated with a nursing home’s whirlpool bath. Commun
    Dis Rep CDR Rev 1995;5:R100–2.
    Vol. 52 / RR-17 Recommendations and Reports 57
  87. Begg N, O’Mahony M, Penny P, Richardson EA, Basavaraj DS. Mycobacterium chelonei associated with a hospital hydrotherapy pool. Community Med 1986;8:348–50.
  88. Laussucq S, Baltch AL, Smith RP, et al. Nosocomial Mycobacterium
    fortuitum colonization from a contaminated ice machine. Am Rev
    Respir Dis 1988;138:891–4.
  89. Struelens MJ, Rost F, Deplano A, et al. Pseudomonas aeruginosa and
    Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak
    investigation using DNA macrorestriction analysis. Am J Med 1993;95:
    489–98.
  90. Kuritsky JN, Bullen MG, Broome CV, Silcox VA, Good RC, Wallace RJ
    Jr. Sternal wound infections and endocarditis due to organisms of the
    Mycobacterium fortuitum complex. Ann Intern Med 1983;98:938–9.
  91. Bolan G, Reingold AL, Carson LA, et al. Infections with Mycobacterium chelonei in patients receiving dialysis and using processed
    hemodialyzers. J Infect Dis 1985;152:1013–9.
  92. Lessing MP, Walker MM. Fatal pulmonary infection due to Mycobacterium fortuitum. J Clin Pathol 1993;46:271–2.
  93. Arnow PM, Chou T, Weil D, Shapiro EN, Kretzschmar C. Nosocomial Legionnaires’ disease caused by aerosolized tap water from respiratory devices. J Infect Dis 1982;146:460–7.
  94. Breiman RF, Fields BS, Sanden GN, Volmer L, Meier A, Spika JS.
    Association of shower use with Legionnaires’ disease: possible role of
    amoebae. JAMA 1990;263:2924–6.
  95. Garbe PL, Davis BJ, Weisfeld JS, et al. Nosocomial Legionnaires’ disease: epidemiologic demonstration of cooling towers as a source. JAMA
    1985;254:521–4.
  96. Fallon RJ, Rowbotham TJ. Microbiological investigations into an outbreak of Pontiac fever due to Legionella micdadei associated with use of
    a whirlpool. J Clin Pathol 1990;43:479–83.
  97. Rose CS, Martyny JW, Newman LS, et al. “Lifeguard lung”: endemic
    granulomatous pneumonitis in an indoor swimming pool. Am J Public Health 1998;88:1795–1800.
  98. CDC. Epidemiologic notes and reports: Legionnaires’ disease outbreak
    associated with a grocery store mist machine—Louisiana, 1989.
    MMWR 1990;39:108–10.
  99. Jacobs RL, Thorner RE, Holcomb JR, Schwietz LA, Jacobs FO.
    Hypersensitivity pneumonitis caused by Cladosporium in an enclosed
    hot-tub area. Ann Intern Med 1986;105:204–6.
  100. Clark A. Bacterial colonization of dental units and the nasal flora of
    dental personnel. Proc Roy Soc Med 1974;67:1269–70.
  101. Fotos PG, Westfall HN, Snyder IS, Miller RW, Mutchler BM. Prevalence of Legionella-specific IgG and IgM antibody in a dental clinic
    population. J Dent Res 1985;64:1382–5.
  102. Reinthaler FF, Mascher F, Stunzner D. Serological examinations for
    antibodies against Legionella species in dental personnel. J Dent Res
    1988;67:942–3.
  103. Putnins EE, Di Giovanni D, Bhullar AS. Dental unit waterline contamination and its possible implications during periodontal surgery.
    J Periodontol 2001;72:393–400.
  104. United States Pharmacopeial Convention. Sterile water for irrigation.
    In: United States Pharmacopeial Convention. United States pharmacopeia and national formulary. USP 24–NF 19. Rockville, MD: United
    States Pharmacopeial Convention, 1997:1753.
  105. Milton DK, Wypij D, Kriebel D, Walters MD, Hammond SK, Evans
    JS. Endotoxin exposure-response in a fiberglass manufacturing facility. Am J Ind Med 1996;29:3–13.
  106. Santiago JI. Microbial contamination of dental unit waterlines: short
    and long term effects of flushing. Gen Dent 1994;42:528–35.
  107. Shearer BG. Biofilm and the dental office. J Am Dent Assoc 1996;
    127:181–9.
  108. Association for the Advancement of Medical Instrumentation, American National Standards Institute. Hemodialysis systems. ANSI/AAMI
    RD5-1992. Arlington, VA: Association for the Advancement of Medical Instrumentation, 1993.
  109. US Environmental Protection Agency. National primary drinking water
    regulations, 1999: list of contaminants. Washington DC: US Environmental Protection Agency, 1999. Available at http://www.epa.gov/
    safewater/mcl.html.
  110. American Public Health Association, American Water Works Association, Water Environment Foundation. In: Eaton AD, Clesceri LS,
    Greenberg AE, eds. Standard methods for the examination of water
    and wastewater. Washington, DC: American Public Health Association, 1999.
  111. Williams HN, Johnson A, Kelley JI, et al. Bacterial contamination of
    the water supply in newly installed dental units. Quintessence Int
    1995;26:331–7.
  112. Scheid RC, Rosen S, Beck FM. Reduction of CFUs in high-speed handpiece water lines over time. Clin Prev Dent 1990;12:9–12.
  113. Williams HN, Kelley J, Folineo D, Williams GC, Hawley CL, Sibiski
    J. Assessing microbial contamination in clean water dental units and
    compliance with disinfection protocol. J Am Dent Assoc 1994;125:
    1205–11.
  114. CDC, Working Group on Waterborne Cryptosporidiosis.
    Cryptosporidium and water: a public health handbook. Atlanta, GA:
    US Department of Health and Human Services, Public Health Service, CDC, 1997.
  115. MacKenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in
    Milwaukee of cryptosporidium infection transmitted through the public
    water supply. N Engl J Med 1994;331:161–7.
  116. Kaminski JC. Cryptosporidium and the public water supply. N Engl
    J Med 1994;331:1529–30.
  117. CDC. Assessing the public health threat associated with waterborne
    cryptosporidiosis: report of a workshop. MMWR 1995;44(No. RR-6).
  118. CDC. Surveillance for waterborne-disease outbreaks—United States,
    1993–1994. MMWR 1996;45(No. SS-1).
  119. Office of Water, US Environmental Protection Agency. Lead and copper rule: summary of revisions. EPA 815–R–99–020. Washington DC:
    US Environmental Protection Agency, 2000.
  120. US Environmental Protection Agency. 65 CFR Parts 141 and 142.
    National primary drinking water regulations for lead and copper, final
    rule. Federal Register 2000;1949–2015.
  121. Gooch B, Marianos D, Ciesielski C, et al. Lack of evidence for patientto-patient transmission of HIV in a dental practice. J Am Dent Assoc
    1993;124:38–44.
  122. Crawford JJ, Broderius C. Control of cross-infection risks in the dental operatory: preventon of water retraction by bur cooling spray systems. J Am Dent Assoc 1988;116:685–7.
  123. Mills SE, Kuehne JC, Bradley DV Jr. Bacteriological analysis of highspeed handpiece turbines. J Am Dent Assoc 1993;124:59–62.
  124. Lewis DL, Arens M, Appleton SS, et al. Cross-contamination potential with dental equipment. Lancet 1992;340:1252–4.
  125. Lewis DL, Boe RK. Cross-infection risks associated with current procedures for using high-speed dental handpieces. J Clin Microbiol
    1992;30:401–6.
    58 MMWR December 19, 2003
  126. Checchi L, Montebugnoli L, Samaritani S. Contamination of the turbine air chamber: a risk of cross infection. J Clin Periodontol
    1998;25:607–11.
  127. Epstein JB, Rea G, Sibau L, Sherlock CH, Le ND. Assessing viral
    retention and elimination in rotary dental instruments. J Am Dent
    Assoc 1995;126:87–92.
  128. Kolstad RA. How well does the chemiclave sterilize handpieces? J Am
    Dent Assoc 1998;129:985–91.
  129. Kuehne JS, Cohen ME, Monroe SB. Performance and durability of
    autoclavable high-speed dental handpieces. NDRI-PR 92-03. Bethesda,
    MD: Naval Dental Research Institute, 1992.
  130. Andersen HK, Fiehn NE, Larsen T. Effect of steam sterilization inside
    the turbine chambers of dental turbines. Oral Surg Oral Med Oral
    Pathol Oral Radiol Endod 1999;87:184–8.
  131. Leonard DL, Charlton DG. Performance of high-speed dental
    handpieces subjected to simulated clinical use and sterilization. J Am
    Dent Assoc 1999;130:1301–11.
  132. Barbeau J, ten Bokum L, Gauthier C, Prevost AP. Cross-contamination
    potential of saliva ejectors used in dentistry. J Hosp Infect 1998;
    40:303–11.
  133. Mann GL, Campbell TL, Crawford JJ. Backflow in low-volume suction lines: the impact of pressure changes. J Am Dent Assoc
    1996;127:611–5.
  134. Watson CM, Whitehouse RL. Possibility of cross-contamination
    between dental patients by means of the saliva ejector. J Am Dent Assoc
    1993;124:77–80.
  135. Glass BJ, Terezhalmy GT. Infection control in dental radiology [Chapter
    15]. In: Cottone JA, Terezhalamy GT, Molinari JA, eds. Practical
    infection control in dentisty. 2nd ed. Baltimore. MD: Williams &
    Wilkins, 1996:229–38.
  136. Haring JI, Jansen L. Infection control and the dental radiographer. In:
    Haring JI, Jansen L, eds. Dental radiography: principles and techniques.
    Philadelphia, PA: WB Saunders Co., 2000:194–204.
  137. Hignett M, Claman P. High rates of perforation are found in
    endovaginal ultrasound probe covers before and after oocyte retrieval
    for in vitro fertilization-embryo transfer. J Assist Reprod Genet
    1995;12:606–9.
  138. Fritz S, Hust MH, Ochs C, Gratwohl I, Staiger M, Braun B. Use of a
    latex cover sheath for transesophageal echocardiography (TEE) instead
    of regular disinfection of the echoscope? Clin Cardiol 1993;16:737–40.
  139. Milki AA, Fisch JD. Vaginal ultrasound probe cover leakage: implications for patient care. Fertil Steril 1998;69:409–11.
  140. Storment JM, Monga M, Blanco JD. Ineffectiveness of latex condoms
    in preventing contamination of the transvaginal ultrasound transducer
    head. South Med J 1997;90:206–8.
  141. Amis S, Ruddy M, Kibbler CC, Economides DL, MacLean AB.
    Assessment of condoms as probe covers for transvaginal sonography.
    J Clin Ultrasound 2000;28:295–8.
  142. Rooks VJ, Yancey MK, Elg SA, Brueske L. Comparison of probe sheaths
    for endovaginal sonography. Obstet Gynecol 1996;87:27–9.
  143. Hokett SD, Honey JR, Ruiz F, Baisden MK, Hoen MM. Assessing the
    effectiveness of direct digital radiography barrier sheaths and finger
    cots. J Am Dent Assoc 2000;131:463–7.
  144. ASHP Council on Professional Affairs. ASHP guidelines on quality
    assurance for pharmacy-prepared sterile products. Am J Health Syst
    Pharm 2000;57:1150–69.
  145. Green KA, Mustachi B, Schoer K, Moro D, Blend R, McGeer A.
    Gadolinium-based MR contrast media: potential for growth of microbial contaminants when single vials are used for multiple patients.
    Am J Roentgenol 1995;165:669–71.
  146. American Society of Anesthesiologists. Recommendations for infection control for the practice of anesthesiology. 2nd ed. Park Ridge,
    IL: American Society of Anesthesiologists,1999.
  147. Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia
    marcescens associated with the anesthetic agent propofol. Am J Infect
    Control 2001;29:312–5.
  148. Plott RT, Wagner RF Jr, Tyring SK. Iatrogenic contamination of
    multidose vials in simulated use. A reassessment of current patient
    injection technique. Arch Dermatol 1990;126:1441–4.
  149. Arrington ME, Gabbert KC, Mazgaj PW, Wolf MT. Multidose vial
    contamination in anesthesia. AANA J 1990;58:462–6.
  150. CDC. Recommendations for preventing transmission of infections
    among chronic hemodialysis patients. MMWR 2001;50(No. RR-5).
  151. Food and Drug Administration. Labeling recommendations for singleuse devices reprocessed by third parties and hospitals; final guidance
    for industry and FDA. Rockville, MD: US Department of Health and
    Human Services, Food and Drug Administration, 2001.
  152. Villasenor A, Hill SD, Seale NS. Comparison of two ultrasonic cleaning units for deterioration of cutting edges and debris removal on dental burs. Pediatr Dent 1992;14:326–30.
  153. Rapisarda E, Bonaccorso A, Tripi TR, Condorelli GG. Effect of sterilization on the cutting efficiency of rotary nickel-titanium endodontic files.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:343–7.
  154. Filho IB, Esberard RM, Leonardo R, del Rio CE. Microscopic evaluation of three endodontic files pre- and postinstrumentation. J Endodontics 1998;24:461–4.
  155. Silvaggio J, Hicks ML. Effect of heat sterilization on the torsional properties of rotary nickel-titanium endodontic files. J Endodontics
    1997;23:731–4.
  156. Kazemi RB, Stenman E, Spangberg LS. The endodontic file is a disposable instrument. J Endodontics 1995;21:451–5.
  157. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial
    endocarditis: recommendations by the American Heart Association.
    JAMA 1990;264:2919–22.
  158. Pallasch TJ, Slots J. Antibiotic prophylaxis and the medically compromised patient. Periodontology 2000 1996;10:107–38.
  159. Litsky BY, Mascis JD, Litsky W. Use of an antimicrobial mouthwash
    to minimize the bacterial aerosol contamination generated by the highspeed drill. Oral Surg Oral Med Oral Pathol 1970;29:25–30.
  160. Mohammed CI, Monserrate V. Preoperative oral rinsing as a means of
    reducing air contamination during use of air turbine handpieces. Oral
    Surg Oral Med Oral Pathol 1970;29:291–4.
  161. Wyler D, Miller RL, Micik RE. Efficacy of self-administered preoperative oral hygiene procedures in reducing the concentration of bacteria in aerosols generated during dental procedures. J Dent Res
    1971;50:509.
  162. Muir KF, Ross PW, MacPhee IT, Holbrook WP, Kowolik MJ. Reduction of microbial contamination from ultrasonic scalers. Br Dent
    J 1978;145:76–8.
  163. Fine DH, Mendieta C, Barnett ML, et al. Efficacy of preprocedural
    rinsing with an antiseptic in reducing viable bacteria in dental aerosols. J Periodontol 1992;63:821–4.
  164. Fine DH, Furgang D, Korik I, Olshan A, Barnett ML, Vincent JW.
    Reduction of viable bacteria in dental aerosols by preprocedural rinsing with an antiseptic mouthrinse. Am J Dent 1993;6:219–21.
    Vol. 52 / RR-17 Recommendations and Reports 59
  165. Fine DH, Yip J, Furgang D, Barnett ML, Olshan AM, Vincent J.
    Reducing bacteria in dental aerosols: pre-procedural use of an antiseptic mouth rinse. J Am Dent Assoc 1993;124:56–8.
  166. Logothetis DD, Martinez-Welles JM. Reducing bacterial aerosol contamination with a chlorhexidine gluconate pre-rinse. J Am Dent Assoc
    1995;126:1634–9.
  167. Klyn SL, Cummings DE, Richardson BW, Davis RD. Reduction of
    bacteria-containing spray produced during ultrasonic scaling. Gen Dent
    2001;49:648–52.
  168. Brown AR, Papasian CJ, Shultz P, Theisen FC, Shultz RE. Bacteremia
    and intraoral suture removal: can an antimicrobial rinse help? J Am
    Dent Assoc 1998;129:1455–61.
  169. Lockhart PB. An analysis of bacteremias during dental extractions.
    A double-blind, placebo-controlled study of chlorhexidine. Arch
    Intern Med 1996;156:513–20.
  170. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial
    endocarditis: recommendations by the American Heart Association.
    JAMA 1997;277:1794–1801.
  171. Tate WH, White RR. Disinfection of human teeth for educational
    purposes. J Dent Educ 1991;55:583–5.
  172. Pantera EA Jr, Zambon JJ, Shih-Levine M. Indirect immunofluorescence for the detection of Bacteroides species in human dental pulp.
    J Endodontics 1988;14:218–23.
  173. Pantera EA Jr, Schuster GS. Sterilization of extracted human teeth.
    J Dent Educ 1990;54:283–5.
  174. Parsell DE, Stewart BM, Barker JR, Nick TG, Karns L, Johnson RB.
    The effect of steam sterilization on the physical properties and perceived cutting characteristics of extracted teeth. J Dent Educ 1998;
    62;260–3.
  175. American Dental Association’s Council on Scientific Affairs and Council on Dental Practice. Infection control recommendations for the dental
    office and the dental laboratory. J Am Dent Assoc 1996;127:672–80.
  176. Dental Laboratory Relationship Working Group, Organization for
    Safety and Asepsis Procedures (OSAP). Laboratory asepsis position
    paper. Annapolis, MD: OSAP Foundation, 1998. Available at http://
    www.osap.org/issues/pages/position/LAB.pdf.
  177. Kugel G, Perry RD, Ferrari M, Lalicata P. Disinfection and communication practices: a survey of U. S. dental laboratories. J Am Dent Assoc
    2000;131:786–92.
  178. US Department of Transportation. 49 CFR 173.196 infectious substances (etiologic agents) 173.197 regulated medical waste. Available
    at http://www.access.gpo.gov/nara/cfr/waisidx_02/49cfr173_02.html.
  179. Chau VB, Saunders TR, Pimsler M, Elfring DR. In-depth disinfection
    of acrylic resins. J Prosthet Dent 1995;74:309–13.
  180. Powell GL, Runnells RD, Saxon BA, Whisenant BK. The presence
    and identification of organisms transmitted to dental laboratories.
    J Prosthet Dent 1990;64:235–7.
  181. Giblin J, Podesta R, White J. Dimensional stability of impression
    materials immersed in an iodophor disinfectant. Int J Prosthodont
    1990;3:72–7.
  182. Plummer KD, Wakefield CW. Practical infection control in dental laboratories. Gen Dent 1994;42:545–8.
  183. Merchant VA. Infection control in the dental laboratory equipment
    [Chapter 16]. In: Cottone JA, Terezhalamy GT, Molinari JA, eds. Practical infection control in dentisty. 2nd ed. Baltimore, MD: Williams &
    Wilkins, 1996:239–54.
  184. Molinari J. Dental. In: Association for Professionals in Infection Control and Epidemiology, Inc. (APIC). APIC text of infection control
    and epidemiology. Washington, DC: Association for Professionals in
    Infection Control and Epidemiology, Inc, 2002.
  185. Sofou A, Larsen T, Fiehn NE, Owall B. Contamination level of alginate impressions arriving at a dental laboratory. Clin Oral Invest
    2002;6:161–5.
  186. McNeill MR, Coulter WA, Hussey DL. Disinfection of irreversible
    hydrocolloid impressions: a comparative study. Int J Prosthodont
    1992;5:563–7.
  187. Gerhardt DE, Sydiskis RJ. Impression materials and virus. J Am Dent
    Assoc 1991;122:51–4.
  188. Leung RL, Schonfeld SE. Gypsum casts as a potential source of microbial cross-contamination. J Prosthet Dent 1983;49:210–1.
  189. Huizing KL, Palenik CJ, Setcos JC, Sheldrake MA, Miller, CH. Method
    of evaluating the antimicrobial abilities of disinfectant-containing gypsum products. QDT Yearbook 1994;17:172–6.
  190. Verran J, Kossar S, McCord JF. Microbiological study of selected risk
    areas in dental technology laboratories. J Dent 1996;24:77–80.
  191. CDC. National Institute for Occupational Safety and Health. NIOSH
    Health Hazard Evaluation and Technical Assistance Report. Cincinnati, OH: US Department of Health and Human Services, Public
    Health Service, CDC, National Institute for Occupational Safety and
    Health, 1988. HETA 85-136-1932.
  192. CDC. National Institute for Occupational Safety and Health. NIOSH
    Health Hazard Evaluation and Technical Assistance Report. Cincinnati, OH: US Department of Health and Human Services, Public
    Health Service, CDC, National Institute for Occupational Safety and
    Health, 1990. HETA 88-101-2008.
  193. CDC. National Institute for Occupational Safety and Health. Control of smoke from laser/electric surgical procedures. Cincinnati, OH:
    US Department of Health and Human Services, Public Health Service, CDC, National Institute for Occupational Safety and Health,
  194. DHHS publication no. (NIOSH) 96-128.
  195. Taravella MJ, Weinberg A, Blackburn P, May M. Do intact viral particles
    survive excimer laser ablation? Arch Ophthalmol 1997;115:1028–30.
  196. Hagen KB, Kettering JD, Aprecio RM, Beltran F, Maloney RK. Lack
    of virus transmission by the excimer laser plume. Am J Ophthalmol
    1997;124:206–11.
  197. Kunachak S, Sithisarn P, Kulapaditharom B. Are laryngeal papilloma
    virus-infected cells viable in the plume derived from a continuous mode
    carbon dioxide laser, and are they infectious? A preliminary report on
    one laser mode. J Laryng Otol 1996;110:1031–3.
  198. Hughes PS, Hughes AP. Absence of human papillomavirus DNA in
    the plume of erbium: YAG laser-treated warts. J Am Acad Dermatol
    1998;38:426–8.
  199. Garden JM, O’Banion MK, Shelnitz LS, et al. Papillomavirus in the
    vapor of carbon dioxide laser-treated verrucae. JAMA 1988;259:
    1199–1202.
  200. Sawchuk WS, Weber PJ, Lowry DR, Dzubow LM. Infectious
    papillomavirus in the vapor of warts treated with carbon dioxide laser
    or electrocoagulation: detection and protection. J Am Acad Dermatol
    1989;21:41–9.
  201. Baggish MS, Poiesz BJ, Joret D, Williamson P, Rafai A. Presence of
    human immunodeficiency virus DNA in laser smoke. Lasers Surg Med
    1991;11:197–203.
  202. Capizzi PJ, Clay RP, Battey MJ. Microbiologic activity in laser resurfacing plume and debris. Lasers Surg Med 1998;23:172–4.
    60 MMWR December 19, 2003
  203. McKinley IB Jr, Ludlow MO. Hazards of laser smoke during endodontic therapy. J Endodontics 1994;20:558–9.
  204. Favero MS, Bolyard EA. Microbiologic considerations. Disinfection
    and sterilization strategies and the potential for airborne transmission
    of bloodborne pathogens. Surg Clin North Am 1995;75:1071–89.
  205. Association of Operating Room Nurses. Recommended practices for
    laser safety in the practice setting. In: Fogg D, ed. Standards, recommended practices and guidelines. Denver, CO: AORN, 2003.
  206. Streifel AJ. Recognizing IAQ risk and implementing an IAQ program.
    In: Hansen W, ed. A guide to managing indoor air quality in health
    care organizations. Oakbrook Terrace, IL: Joint Commission on
    Accreditation of Healthcare Organizations Publishers, 1997.
  207. US Department of Labor, Occupational Safety and Health Administration. Safety and health topics: laser/electrosurgery plume. Washington DC: US Department of Labor, Occupational Safety and Health
    Administration, 2003. Available at http://www.osha-slc.gov/SLTC/
    laserelectrosurgeryplume.
  208. American Thoracic Society, CDC. Diagnostic standards and classification of tuberculosis in adults and children. Am J Resp Crit Care
    2000;161:1376–95.
  209. Wells WF. Aerodynamics of droplet nuclei [Chapter 3]. In: Wells WF,
    ed. Airborne contagion and air hygiene: an ecological study of droplet
    infections. Cambridge, MA: Harvard University Press, 1955.
  210. CDC. Prevention and treatment of tuberculosis among patients
    infected with human immunodeficiency virus: principles of therapy
    and revised recommendations. MMWR 1998;47(No. RR-20).
  211. Smith WH, Davies D, Mason KD, Onions JP. Intraoral and pulmonary tuberculosis following dental treatment. Lancet 1982;1:842–4.
  212. CDC. Self-reported tuberculin skin testing among Indian Health Service and Bureau of Prisons dentists, 1993. MMWR 1994;43:209–11.
  213. Mikitka D, Mills SE, Dazey SE, Gabriel ME. Tuberculosis infection in
    US Air Force dentists. Am J Dent 1995;8:33–6.
  214. CDC. World Health Organization consultation on public health issues
    related to bovine spongiform encephalopathy and the emergence of a
    new variant of Creutzfeldt-Jakob Disease. MMWR 1996;45:295–6.
  215. CDC. Surveillance for Creutzfeldt-Jakob disease—United States.
    MMWR 1996;45:665–8.
  216. Johnson RT, Gibbs CJ Jr. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med 1998;339:
    1994–2004.
  217. CDC. New variant CJD: fact sheet. Atlanta, GA: US Department of
    Health and Human Services, Public Health Service, CDC, 2003. Available at http://www.cdc.gov/ncidod/diseases/cjd/cjd_fact_sheet.htm.
  218. Will RG, Ironside JW, Zeidler M, et al. A new variant of CreutzfeldtJakob disease in the UK. Lancet 1996;347:921–5.
  219. Bruce ME, Will RG, Ironside JW, et al. Transmission to mice indicate
    that ‘new variant’ CJD is caused by the BSE agent. Nature 1997;389:
    498–501.
  220. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis
    of prion strain variation and the aetiology of ‘new variant’ CJD.
    Nature 1996;383:685–90.
  221. World Health Organization. Bovine spongiform encephalopathy (BSE).
    Fact Sheet No. 113. Geneva, Switzerland: World Health Organization, 2002. Available at http://www.who.int/mediacentre/factsheets/
    fs113/en/.
تاريخ : سه شنبه پانزدهم م اسفند ۱۴۰۱ | 16:43 | نویسنده : دکتر طالبیان |

تمام حقوق این سایت متعلق به دکتر علیرضا طالبیان میباشد

Copyright © 2023 drtalebian.blogfa.com. All Rights Reserved